Food and Drug Administration
Cooperative Agreement to Support Activities Related to Analgesics, Anesthetics, and Addiction (U01) Clinical Trials Allowed
About This Grant
To develop, disseminate, implement, and evaluate research needed in Anesthesia, Addiction Medicine and Pain Medicine in various fields of research. Specifically, research is needed in the following fields: function as a clinical trial endpoint and measurement of function in patients with chronic pain, outcome measures for clinical trials in stimulant use disorders, assessment of opioid clinical trials with active control in addition to placebo, neurodevelopmental outcome assessment of vulnerable pediatric patients exposed to anesthesia and opioid, and a living systematic review of pre-clinical studies of anesthetic neurotoxicity. Multiple awards may be considered. Applicants must propose a comprehensive evidence-based plan that advances appropriate prescribing of drug products intended for analgesia, anesthesia, and substance use disorders.
Who Can Apply
Focus Areas
Additional Details
- CFDA / ALN Number
- 93.103
- Program Title
- Food and Drug Administration Research
- Expected Awards
- 5
- Source
- Grants.gov · View original listing
Similar Grants
Bureau of Indian Affairs
Energy and Mineral Development Program (EMDP) Grant
$10K – $2.5MDue June 18, 2026U.S. Mission to Poland
Freedom 250 Poland 2026
$10K – $40KDue June 14, 2026Bureau of Counterterrorism
Strengthening Transit Security and Economic Protection in Mozambique
$4M – $4.9MDue June 9, 2026Bureau of Counterterrorism
Strengthening Early Warning, Detection, & Response in Mozambique
$2M – $3.0MDue June 9, 2026Food and Drug Administration
Novel Approaches to Support Therapeutic Development in Ultra-Rare Cancers
Up to $500KDue June 15, 2026U.S. Mission to Uganda
American Center Kampala Management and Programming
$30K – $70KDue May 29, 2026 (21 days away)